Physician
Internal Medicine
Dr. Wolfram E. Samlowski, MD
|
|
Give Review
Dr. Wolfram E. Samlowski is an expert in the field of Internal Medicine. He went to Wayne State University School of Medicine. Wayne State University School of Medicine is ranked 63/85 in Research/PrimaryCare. He has 5 awards "Vegas Seven", "America's Top Doctors", "America's Top Doctors for Cancer", "Meaningful Use Stage 1 Certification" and "Desert Companion". Wolfram Samlowski is a published doctor as well. He has 36 publications published. The latest was: Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology. He accepts Medicare.
Publications
- Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology.
- Recent advances in the understanding of the genetics, etiology, and treatment of merkel cell carcinoma.
- Clinical Cancer Advances 2011: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
- The depletion of DNA Methyltransferase-1 and the epigenetic effects of 5-Aza-2'Deoxycytidine (Decitabine) are differentially regulated by cell cycle progression.
- Large cell non-Hodgkin's lymphoma masquerading as renal carcinoma with inferior vena cava thrombosis: a case report.
- Endothelial nitric oxide synthase is a key mediator of interleukin-2-induced hypotension and vascular leak syndrome.
- A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma.
- Management of melanoma brain metastases in the era of targeted therapy.
- A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331).
- A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma.
- Patterns of enlarged lymph nodes in patients with metastatic renal cell carcinoma.
- A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma.
- Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
- From the guest editors: the dramatic advances in the treatment of metastatic renal cancer that have occurred over the last 3 years, with an eye toward the potential fu...
- Conclusion and future directions.
- Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree.
- Inducible nitric oxide synthase (iNOS) is not required for IL-2-induced hypotension and vascular leak syndrome in mice.
- N-acetylcysteine protects melanocytes against oxidative stress/damage and delays onset of ultraviolet-induced melanoma in mice.
- Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases.
- Management of metastatic melanoma patients with brain metastases.
- Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous ...
- Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
- Evaluation of the combination of docetaxel/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN): a Southwest Oncol...
- ReGel polymer-based delivery of interleukin-2 as a cancer treatment.
- Population-based prevalence of CDKN2A mutations in Utah melanoma families.
- Nevus distribution in a Utah melanoma kindred with a temperature-sensitive CDKN2A mutation.
- Molecular classification of melanoma using real-time quantitative reverse transcriptase-polymerase chain reaction.
- Population-based analysis of prognostic factors and survival in familial melanoma.
- Evaluation of a 7-day continuous intravenous infusion of decitabine: inhibition of promoter-specific and global genomic DNA methylation.
- Longitudinal assessment of the nevus phenotype in a melanoma kindred.
- A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncol...
- Reversible diplopia induced by high-dose intravenous IL-2 therapy.
- A nonpeptidyl mimic of superoxide dismutase, M40403, inhibits dose-limiting hypotension associated with interleukin-2 and increases its antitumor effects.
- Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant.
- Failure to detect differences in proliferation status of nevi from CDKN2A mutation carriers and non-carriers.
Schools
Ohio State University College Of Medicine
Wayne State
Wayne St University Dmc
University of Utah
Procedures Preformed
- Biological Therapy
- Cancer Treatment
- Hematologic Disorder Treatment
- Immunotherapy
Doctors Specialties
- Adult Hematology
- Cancer Immunology
- Cancer Research
- Dermatologic Oncology
- Hematology
- Internal Medicine
- Medical Oncology
- Oncology
- Urologic Oncology
Accepted Insurances
Awards
- Vegas Seven
- America's Top Doctors
- America's Top Doctors for Cancer
- Meaningful Use Stage 1 Certification
- Desert Companion
Education
-
University of Utah -
Wayne State University School of Medicine -
The Ohio State University College of Medicine
Drug Facts
| NPI NUMBER | 1396810834 | |
| NPPES Provider LastName | SAMLOWSKI | |
| NPPES Provider FirstName | WOLFRAM | |
| NPPES Provider ZIPCode | 89148 | |
| NPPES Provider State | NV | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 894.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 147.0 | |
| Percent Opioid Claims | 16.44 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1396810834 |
| Last Name Of The Provider | SAMLOWSKI |
| First Name Of The Provider | WOLFRAM |
| View All |
Similar Doctors
|
Dr. Chinenye Ezeanolue, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mandip S. Arora, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Agnes P. Mortel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan D. Marvin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sheryl A. Yu, MD |
|
|
Dr. Gregory K. Bryan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nicholas J. Vogelzang, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Anoush H. Tacvorian, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan M. Myers, MD |
|
|
Dr. Michael D. Stein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark E. McKenzie, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ghulam H. Kashef, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shyam Shah, MD |
|
Dr. Fadi Braiteh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dana Cruz, DO |
|
|
Dr. David Hyun-soo Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Beth M. Laine, MD |
|
Dr. Edwin C. Kingsley, MD |
|
Dr. Holavanahall S. Keshava-Prasad, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Randy R. Calegari, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Oscar B. Goodman Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Wael Eid, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Heather J. Allen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Coon, MD
This Doctor is OpenDoctor Recommended.
|